Lv1
15 积分 2020-08-03 加入
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
8小时前
已完结
From NASH to HCC: current concepts and future challenges
19天前
已完结
Immune cell-mediated features of non-alcoholic steatohepatitis
19天前
已完结
Targeting mitophagy in neurodegenerative diseases
20天前
已完结
Food inequity and insecurity and MASLD: burden, challenges, and interventions
21天前
已完结
A roadmap for clinical trials in MASH-related compensated cirrhosis
21天前
已完结
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
21天前
已完结
Immune cell-mediated features of non-alcoholic steatohepatitis
24天前
已完结
RNAi-based drug design: considerations and future directions
24天前
已完结
Nonalcoholic fatty liver disease
24天前
已完结
皖公网安备34019202002308
